Inflammatory cytokines and depression in children with cancer: A review of the literature

References

• Ransahoff R, Benveniste E. Cytokines and the CNS. New York, NY: Taylor & Francis Group; 2006.
   Google Scholar
• Rothwell N, Loddick S. Immune and Inflammatory Responses in the Nervous System. New York, NY: Oxford University Press; 2002.
   Google Scholar
• Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29:247–264.
   PubMed Web of Science ®Google Scholar
• Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013;246:199–229.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21(2):153–160.
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin. 2006;24(3):441.
   PubMed Web of Science ®Google Scholar
• Pyter LM, Pineros V, Galang JA, et al. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc Natl Acad Sci USA 2009;106(22):9069–9074.
   PubMed Web of Science ®Google Scholar
• Asnis GM, De La Garza R. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 2006;40(4):322–335.
   PubMed Web of Science ®Google Scholar
• Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004;25(3):94–102.
   PubMed Web of Science ®Google Scholar
• Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003;54(3):283–294.
   PubMed Web of Science ®Google Scholar
• Goodyer I. Emmanuel Miller lecture: Early onset depressions – meanings, mechanisms and processes. J Child Psychol Psychiatry. 2008;49:1239–1256.
   PubMed Web of Science ®Google Scholar
• Jaffee SR, Moffitt TE, Caspi A, et al. Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry. 2002;59(3):215–222.
   PubMed Web of Science ®Google Scholar
• Li HC, Chung OK, Chiu SY. The impact of cancer on children's physical, emotional, and psychosocial well-being. Cancer Nurs. 2010;33(1):47–54.
   PubMed Web of Science ®Google Scholar
• Myers RM, Balsamo L, Lu X, et al. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia. Cancer 2014;120(9):1417–1425.
   PubMed Web of Science ®Google Scholar
• Dejong M, Fombonne E. Depression in paediatric cancer: an overview. Psycho Oncology. 2006;15(7):553–66. doi:10.1002/pon.1002. PMID:16355435
   PubMed Web of Science ®Google Scholar
• Barrera M, Schulte F, Spiegler B. Factors influencing depressive symptoms of children treated for a brain tumor. J Psychosol Oncol. 2007 Dec 4;26(1):1–6.
   Web of Science ®Google Scholar
• Li HC, Williams PD, Lopez V, et al. Relationships among therapy-related symptoms, depressive symptoms, and quality of life in Chinese children hospitalized with cancer: an exploratory study. Cancer Nurs. 2013;36(5):346–354.
   PubMed Web of Science ®Google Scholar
• Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26(5):643–652.
   PubMed Web of Science ®Google Scholar
• Edgell T, Martin-Roussety G, Barker G, et al. Phase II biomarker trial of a multimarker diagnostic for ovarian cancer. J Cancer Res Clin Oncl. 2010;136(7):1079–1088.
   PubMed Web of Science ®Google Scholar
• Lee BN, Dantzer R, Langley KE, et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. NeuroImmunoModulation 2004;11(5):279–292.
   PubMed Web of Science ®Google Scholar
• Barsness KA, Bensard DD, et al. IL-1β induces an exaggerated pro-and anti-inflammatory response in peritoneal macrophages of children compared with adults. Pediatr Surg Int. 2004;20(4):238–242.
   PubMed Web of Science ®Google Scholar
• Barsness KA, Bensard DD, Partrick DA, et al. Endotoxin induces an exaggerated interleukin-10 response in peritoneal macrophages of children compared with adults. J Pediatr Surg. 2004;39(6):912–915.
   PubMed Web of Science ®Google Scholar
• Finnerty CC, Jeschke MG, Herndon DN, et al. Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med. 2008;14(9–10):553.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Aziz N, et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604–611.
   PubMed Web of Science ®Google Scholar
• Esmaeeli MR, Sayar RE, Saghebi A, et al. Screening for depression in hospitalized pediatric patients. Iran J Child Neurol. 2014;8(1):47–51.
   PubMedGoogle Scholar
• Hockenbery M, Dilorio C, Kemp V. The relationship of illness longevity and relapse with self-perception, cancer stressors, anxiety and coping strategies in children with cancer. J Pediatr Oncol Nurs. 1995;12:71–79.
   PubMedGoogle Scholar
• McDaniel JS, Musselman DL, Porter MR, et al. Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52(2):89–99.
   PubMed Web of Science ®Google Scholar
• Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
   PubMedGoogle Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.
   PubMed Web of Science ®Google Scholar
• Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biohav Rev. 2005;29(4):891–909.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009 May 1;65(9):732–741.
   PubMed Web of Science ®Google Scholar
• Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol. 1999;461:25–46.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A metaanalysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–186.
   PubMed Web of Science ®Google Scholar
• Maes M, Lambrechts J, Bosmans E, et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med. 1992;22:45–53.
   PubMed Web of Science ®Google Scholar
• Sluzewska A. Indicators of immune activation in depressed patients. Adv Exp Med Biol. 1999;461:59–73.
   PubMed Web of Science ®Google Scholar
• Harrison NA, Brydon L, Walker C, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66(5):407–414.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001 May 1;58(5):445–452.
   PubMed Web of Science ®Google Scholar
• Gabbay V, Klein RG, Guttman LE, et al. A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression. J Child Adolesc Psychopharmacol. 2009;19(4):423–430.
   PubMed Web of Science ®Google Scholar
• Pandey GN, Rizavi HS, Ren X, et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. Psychiatry Res. 2012;46(1):57–63.
   Google Scholar
• Abbott R, Whear R, Nikolaou V, et al. Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res. 2015;79:175–184.
   PubMed Web of Science ®Google Scholar
• Köhler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA psychiatry. 2014;71(12):1381–1391.
   PubMed Web of Science ®Google Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31–41.
   PubMed Web of Science ®Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet North Am Ed. 2006;367(9504):29–35.
   PubMed Web of Science ®Google Scholar
• Obata NH, Tamakoshi K, Shibata K, et al. Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma. Anticancer Res 1996;17(1A):337–342.
   Web of Science ®Google Scholar
• Jehn CF, Kuehnhardt D, Bartholomae A, et al. Biomarkers of depression in cancer patients. Cancer 2006;107:2723–2729.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344(13):961–966.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Gennarelli M, Uher R, et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology. 2013;38(3):377–385.
   PubMed Web of Science ®Google Scholar
• Eurelings LS, Richard E, Eikelenboom P, et al. Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals. Int Psychogeriatr. 2015;27(04):639–647.
   PubMedGoogle Scholar
• Michopoulos V, Rothbaum AO, Jovanovic T, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry. 2015;172(4):353–362.
   PubMed Web of Science ®Google Scholar
• Miller AH, Haroon E, Raison CL, et al. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 2013;30(4):297–306.
   PubMed Web of Science ®Google Scholar
• Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014;140:774–815.
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, O'Brien SM, Scully P, et al. Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med. 2006;36:37–43.
   PubMed Web of Science ®Google Scholar
• Lanquillon S, Krieg JC, Bening-Abu-Shach U, et al. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22:370–379.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917.
   PubMed Web of Science ®Google Scholar
• Sluzewska A, Sobieska M, Rybakowski JK. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 1997;35:123–127.
   PubMed Web of Science ®Google Scholar
• McNutt MD, Liu S, Manatunga A, et al. Neurobehavioral effects of interferon-alpha in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology 2012;37:1444–1454.
   PubMed Web of Science ®Google Scholar
• Raison CL, Woolwine BJ, Demetrashvili MF, et al. Paroxetine for prevention of depressive symptoms induced by interferon‐alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther. 2007;25(10):1163–1174.
   PubMed Web of Science ®Google Scholar
• Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971–982.
   PubMed Web of Science ®Google Scholar
• Raison CL, Miller AH. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry. 2013;18(1):15–37.
   PubMed Web of Science ®Google Scholar
• Bosker FJ, Hartman CA, Nolte IM, et al. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry. 2011;16:516–532.
   PubMed Web of Science ®Google Scholar
• Bufalino C, Hepgul N, Aguglia E, et al. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav Immun. 2013;31:31–47.
   PubMed Web of Science ®Google Scholar
• Foley DL, Neale MC, Gardner CO, et al. Major depression and associated impairment: same or different genetic and environmental risk factors? Am J Psychiatry. 2003;160:2128–2133.
   PubMed Web of Science ®Google Scholar
• Jang KL, Livesley WJ, Taylor S, et al. Heritability of individual depressive symptoms. J Affect Disord 2004;80:125–133.
   PubMed Web of Science ®Google Scholar
• Kersun LS, Rourke MT, Mickley M, et al. Screening for depression and anxiety in adolescent cancer patients. Pediatr Blood Cancer 2009;31(11):835–839.
   Google Scholar
• Dunitz M, Scheer PJ, Wurst L, et al. Depression in children with cancer. Padiatr Padol. 1990;26(6):267–270.
   Google Scholar
• Kersun LS, Elia J. Depressive symptoms and SSRI use in pediatric oncology patients. Pediatr Blood Cancer 2007;49(7):881–887.
   PubMed Web of Science ®Google Scholar
• Danese A, Moffitt TE, Pariante CM, et al. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry. 2008;65(4):409–415.
   PubMed Web of Science ®Google Scholar